Health
UAE company nears end of Chinese Covid-19 vaccine trial – Arab News
ABU DHABI: A United Arab Emirates company is nearing the end of Phase III clinical trials of a Chinese COVID-19 vaccine and hopes to manufacture it next year, a…
ABU DHABI: A United Arab Emirates company is nearing the end of Phase III clinical trials of a Chinese COVID-19 vaccine and hopes to manufacture it next year, a representative said.The trial, which began in mid-July, is a partnership between Sinopharms China National Biotec Group (CNBG) and Abu Dhabi-based artificial intelligence and cloud computing company Group 42 (G42).The vaccine uses an inactivated virus; a well-known technology which has been used against diseases such as influenza and mea…
-
Business18 hours agoWhy Vault Minerals, Droneshield, Westgold Resources shares are climbing higher today
-
General23 hours agoBrick portico a relic of ‘prestigious’ Horton College in northern midlands
-
Noosa News13 hours agoRacing Queensland responds to criticism of ‘deadliest’ greyhound track
-
Noosa News20 hours agoQueenslanders to continue legal challenges against COVID-19 directives after successful appeal